Primary Job Title CEO, Director and Founder Primary Organization 
Ixchelsis
Location Ash, Essex, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Gary MuirheadGary graduated in Applied Biology from Cardiff University in 1979 and then trained and was employed as a Clinical Biochemist at the University Hospital of Wales and Surrey County Hospital through to 1986. Gary then joined Roche as a Team Leader and Senior Scientist, Pharmacokinetics/Drug Metabolism.
In 1993 Gary joined the
Pfizer Clinical Pharmacology group in Sandwich and held positions of increasing responsibility over the subsequent 14 years. As well as managing the Clinical Pharmacologists and providing strategic leadership in the GI, GU/Sex Health and Anti-viral therapeutic areas, Gary was also the Global Clinical Pharmacology lead for a number of successful drugs including Viagra, Celsentry®, and Geodon®. Gary also acted as Early Clinical Leader for a number of GU/Sex Health projects during this period. In 2006 Gary was appointed Sandwich Site Head for Clinical Research Operations and successfully built a group responsible for the operational delivery of exploratory development, clinical pharmacology and clinical technology clinical studies.
In June 2009 Gary was appointed to the position of Vice President, Clinical Affairs Site Head for Specialty Care in Sandwich. In this position Gary managed the clinicians, statisticians and clinical pharmacologists, ensuring the provision of quality resources to the Asset Teams.
Gary is now Founder and Chief Executive Officer of Ixchelsis Ltd a Pfizer Sandwich Start-up focusing on developing drugs in Men’s Health indications.
